Johnson & Johnson Skids Despite First-Quarter Beat, Sales Guidance Hike
In This Article:
Johnson & Johnson stock fell alongside the broader market, despite beating first-quarter calls and hiking its 2025 sales guidance.
We are experiencing some temporary issues. The market data on this page is currently delayed. Please bear with us as we address this and restore your personalized lists.